Forbes Medi-Tech

Forbes Medi-Tech sees Q1 growth on Reducol sales

16-May-2007 By staff reporter

Reducol-maker Forbes Medi-Tech has reported strong results for the
first quarter ended March 31, 2007, as it looks to expand its
portfolio.

Forbes Medi-Tech sees revenue up in fiscal 2006

29-Mar-2007 By Clarisse Douaud

Forbes Medi-Tech has reported in its year-end financial report that
sales of Reducol continue to increase and offset operating losses.

Forward-looking Forbes Medi-Tech racks up R&D losses

31-Mar-2006 By staff reporter

Forbes Medi-Tech is expecting future growth for its branded
nutraceutical business to be borne of its milestone deal with
leading UK retailer Tesco, yet is philosophical that it will
continue reporting losses until one of its ventures...

Forbes Medi-Tech completes sale of Phyto-Source share

14-Mar-2006 By Jess Halliday

Forbes Medi-Tech has completed the sale of its 50 percent share in
Phyto-Source, its sterol manufacturing joint venture with Chusei
(USA) to Chusei Oil Co for US$25 million, and plans to use the
proceeds to develop more nutraceutical...

Forbes MediTech, Pharmavite extend Reducol agreement again

14-Feb-2006 By staff reporter

Forbes MediTech is to continue supplying Pharmavite with its
Reducol cholesterol-lowering ingredient until at least mid-2007, in
an extension of the existing supply and license agreements.

Nutraceuticals drive development at Forbes Medi-Tech

04-Apr-2005

Forbes Medi-Tech has reported a 23 percent increase in sales for
full year 2004 to C$17.04 million, almost all of which was
generated by its nutraceutical business.

Fortune favors Forbes Medi-Tech for 2005

13-Jan-2005

2005 is barely underway but Canadian Forbes Medi-Tech is already
looking forward to a bumper year. The biopharmaceutical company
yesterday announced revenue guidance of C$21 to C$22 million for
the fiscal year ending 31 December 2005...

Good news from Europe for Forbes Medi-Tech

16-Dec-2003

Canadian firm Forbes Medi-Tech saw shares jump 10 per cent this
week following the announcement by the European Food Safety Agency
(EFSA) that its cholesterol-lowering ingredient Reducol is safe.

Forbes ups production capacity

09-Dec-2003

Canadian sterols maker Forbes Medi-Tech has begun work to expand
manufacturing of phytosterols at its facility in Pasadena, Texas.

Forbes restructures

24-Oct-2002

Canadian company Forbes Medi-Tech has announced several changes in
the company'soperations and management structure, and is to
outsource its research to universities and contract research
organisations.

Sterols agreement for Forbes

19-Sep-2002

Forbes Medi-Tech, a Canadian developer of nutraceuticals and
pharmaceuticals has received two-year sterols supply agreements
valued at up to C$40 million (€26m) from undisclosed customers,
reports Dow Jones this week.